Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure ...
A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback